Neill Sun
Pulmonary Hypertension (PH) is a progressive condition characterized by elevated blood pressure in the pulmonary arteries, leading to right heart failure and significant morbidity and mortality. Hemolytic Anemia (HA), a group of disorders characterized by premature destruction of red blood cells, has been increasingly recognized as a potential cause or contributor to pulmonary hypertension. This mini-review explores the pathophysiological mechanisms linking hemolytic anemia to pulmonary hypertension, clinical presentations, diagnostic challenges, management strategies, and outcomes based on current literature and clinical insights.
Compartilhe este artigo
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Hindi 